Literature DB >> 19556330

Ghrelin resistance occurs in severe heart failure and resolves after heart transplantation.

Lars H Lund1, Jill J Williams, Pamela Freda, John J LaManca, Thierry H LeJemtel, Donna M Mancini.   

Abstract

AIMS: Severe heart failure (HF) is often associated with cachexia that reverses post-heart transplantation (HTx) with frequent development of obesity. Ghrelin is a novel appetite-stimulating hormone. The aim was to determine the role of ghrelin in regulating appetite, food intake, and body composition in HF and post-HTx. METHODS AND
RESULTS: We measured serial ghrelin, hunger sensation, caloric intake, and body composition in 12 HF patients awaiting HTx, 12 patients 12.7 +/- 8.6 months post-HTx, and 7 controls. Seven of 12 HF patients were followed for longitudinal analysis post-HTx. Body mass index was 23.1 +/- 3.1 in HF and 31.5 +/- 5.5 post-HTx (P < 0.001). Heart transplantation patients had gained 18.0 +/- 7.7 kg since HTx. Ghrelin area under the curve between controlled meals (control: 186 +/- 39; HF: 264 +/- 71; HTx: 194 +/- 47 ng min/mL, P < 0.007) was higher in HF, but test meal caloric intake (control: 1185 +/- 650; HF: 391 +/- 103; HTx: 831 +/- 309 kcal, P < 0.008) was lower in HF. The longitudinal analysis confirmed these findings.
CONCLUSION: Heart failure may be associated with resistance to the appetite-stimulating effects of ghrelin, which may contribute to cachexia. Heart transplantation may be associated with resolution of ghrelin resistance, which may contribute to weight gain. These findings are preliminary and should be confirmed in larger trials.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19556330      PMCID: PMC2715223          DOI: 10.1093/eurjhf/hfp088

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  20 in total

1.  Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa.

Authors:  B Otto; U Cuntz; E Fruehauf; R Wawarta; C Folwaczny; R L Riepl; M L Heiman; P Lehnert; M Fichter; M Tschöp
Journal:  Eur J Endocrinol       Date:  2001-11       Impact factor: 6.664

2.  Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure.

Authors:  D M Mancini; G Walter; N Reichek; R Lenkinski; K K McCully; J L Mullen; J R Wilson
Journal:  Circulation       Date:  1992-04       Impact factor: 29.690

3.  Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion.

Authors:  Tomomi Shiiya; Masamitsu Nakazato; Masanari Mizuta; Yukari Date; Muhtashan S Mondal; Muneki Tanaka; Shin-Ichi Nozoe; Hiroshi Hosoda; Kenji Kangawa; Shigeru Matsukura
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

4.  Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone.

Authors:  S D Anker; M Volterrani; C D Pflaum; C J Strasburger; K J Osterziel; W Doehner; M B Ranke; P A Poole-Wilson; A Giustina; R Dietz; A J Coats
Journal:  J Am Coll Cardiol       Date:  2001-08       Impact factor: 24.094

5.  Growth hormone secretagogue binding sites in peripheral human tissues.

Authors:  M Papotti; C Ghè; P Cassoni; F Catapano; R Deghenghi; E Ghigo; G Muccioli
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

6.  Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors.

Authors:  N Nagaya; M Uematsu; M Kojima; Y Date; M Nakazato; H Okumura; H Hosoda; W Shimizu; M Yamagishi; H Oya; H Koh; C Yutani; K Kangawa
Journal:  Circulation       Date:  2001-10-23       Impact factor: 29.690

7.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

Review 8.  Nutritional status in the neuroendocrine control of growth hormone secretion: the model of anorexia nervosa.

Authors:  Massimo Scacchi; Angela Ida Pincelli; Francesco Cavagnini
Journal:  Front Neuroendocrinol       Date:  2003-07       Impact factor: 8.606

9.  Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans.

Authors:  Mitsunobu Enomoto; Noritoshi Nagaya; Masaaki Uematsu; Hiroyuki Okumura; Eiichiroh Nakagawa; Fumiaki Ono; Hiroshi Hosoda; Hideo Oya; Masayasu Kojima; Katsuo Kanmatsuse; Kenji Kangawa
Journal:  Clin Sci (Lond)       Date:  2003-10       Impact factor: 6.124

10.  Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Authors:  J G Carr; L W Stevenson; J A Walden; D Heber
Journal:  Am J Cardiol       Date:  1989-03-15       Impact factor: 2.778

View more
  12 in total

1.  Leptin resistance after heart transplantation.

Authors:  Lars H Lund; Pamela Freda; Jill J Williams; John J LaManca; Thierry H LeJemtel; Donna M Mancini
Journal:  Eur J Heart Fail       Date:  2010-03-01       Impact factor: 15.534

Review 2.  Frailty in the End-Stage Lung Disease or Heart Failure Patient: Implications for the Perioperative Transplant Clinician.

Authors:  Brandi A Bottiger; Alina Nicoara; Laurie D Snyder; Paul E Wischmeyer; Jacob N Schroder; Chetan B Patel; Mani A Daneshmand; Robert N Sladen; Kamrouz Ghadimi
Journal:  J Cardiothorac Vasc Anesth       Date:  2018-08-09       Impact factor: 2.628

3.  Acylation of ghrelin is increased in heart failure and decreases post heart transplantation.

Authors:  Stanislava Zabarovskaja; Pamela Freda; Jill J Williams; Chandra Kunavarapu; John Lamanca; Donna Mancini; Lars H Lund
Journal:  Scand Cardiovasc J       Date:  2014-09-18       Impact factor: 1.589

Review 4.  The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism.

Authors:  Mark D DeBoer
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  Plasma Levels of Acylated Ghrelin in Children with Pulmonary Hypertension Associated with Congenital Heart Disease.

Authors:  Gang Li; Jiyi Xia; Peng Jia; Jian Zhao; Yuqin Sun; Changxue Wu; Bin Liu
Journal:  Pediatr Cardiol       Date:  2015-05-17       Impact factor: 1.655

Review 6.  Muscle wasting and cachexia in heart failure: mechanisms and therapies.

Authors:  Stephan von Haehling; Nicole Ebner; Marcelo R Dos Santos; Jochen Springer; Stefan D Anker
Journal:  Nat Rev Cardiol       Date:  2017-04-24       Impact factor: 32.419

7.  Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams.

Authors:  Candyce H Kroenke; Romain Neugebauer; Jeffrey Meyerhardt; Carla M Prado; Erin Weltzien; Marilyn L Kwan; Jingjie Xiao; Bette J Caan
Journal:  JAMA Oncol       Date:  2016-09-01       Impact factor: 31.777

8.  Research on cachexia, sarcopenia and skeletal muscle in cardiology.

Authors:  Andrew J S Coats
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-11-16       Impact factor: 12.910

9.  B-type natriuretic peptide modulates ghrelin, hunger, and satiety in healthy men.

Authors:  Greisa Vila; Gabriele Grimm; Michael Resl; Birgit Heinisch; Elisa Einwallner; Harald Esterbauer; Benjamin Dieplinger; Thomas Mueller; Anton Luger; Martin Clodi
Journal:  Diabetes       Date:  2012-06-14       Impact factor: 9.461

Review 10.  Ghrelin.

Authors:  T D Müller; R Nogueiras; M L Andermann; Z B Andrews; S D Anker; J Argente; R L Batterham; S C Benoit; C Y Bowers; F Broglio; F F Casanueva; D D'Alessio; I Depoortere; A Geliebter; E Ghigo; P A Cole; M Cowley; D E Cummings; A Dagher; S Diano; S L Dickson; C Diéguez; R Granata; H J Grill; K Grove; K M Habegger; K Heppner; M L Heiman; L Holsen; B Holst; A Inui; J O Jansson; H Kirchner; M Korbonits; B Laferrère; C W LeRoux; M Lopez; S Morin; M Nakazato; R Nass; D Perez-Tilve; P T Pfluger; T W Schwartz; R J Seeley; M Sleeman; Y Sun; L Sussel; J Tong; M O Thorner; A J van der Lely; L H T van der Ploeg; J M Zigman; M Kojima; K Kangawa; R G Smith; T Horvath; M H Tschöp
Journal:  Mol Metab       Date:  2015-03-21       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.